News
Results, big moves, analysis and research from Fundamentalytics, newest first. Every figure is checked against SEC filings.
-
What to watch when Berkshire Hathaway reports on Saturday 7 November
Berkshire Hathaway reports on Saturday 7 November, after the market closes. Analysts expect full-year EPS of $22.47; these are the numbers and trends the report will test.
-
What to watch when Calumet, Inc. reports on Friday 6 November
Calumet, Inc. reports on Friday 6 November, before the market opens. Analysts expect full-year EPS of −$1.65; these are the numbers and trends the report will test.
-
What to watch when Charter Communications reports on Friday 6 November
Charter Communications reports on Friday 6 November, before the market opens. Analysts expect full-year EPS of $40.36; these are the numbers and trends the report will test.
-
What to watch when Kimberly-Clark reports on Thursday 5 November
Kimberly-Clark reports on Thursday 5 November, before the market opens. Analysts expect full-year EPS of $7.39; these are the numbers and trends the report will test.
-
What to watch when Lyft, Inc. reports on Thursday 5 November
Lyft, Inc. reports on Thursday 5 November, after the market closes. Analysts expect full-year EPS of $0.54; these are the numbers and trends the report will test.
-
What to watch when Moderna reports on Friday 6 November
Moderna reports on Friday 6 November, before the market opens. Analysts expect full-year EPS of −$8.49; these are the numbers and trends the report will test.
-
What to watch when Ubiquiti Inc. reports on Friday 6 November
Ubiquiti Inc. reports on Friday 6 November, before the market opens. Analysts expect full-year EPS of $17.71; these are the numbers and trends the report will test.
-
What to watch when US Foods Holding Corp. reports on Thursday 5 November
US Foods Holding Corp. reports on Thursday 5 November, before the market opens. Analysts expect full-year EPS of $4.77; these are the numbers and trends the report will test.
-
Neurocrine shares rose 13.4% as Q3 beat and INGREZZA guidance climbed
Neurocrine Biosciences shares rose 13.4% on Tuesday after third-quarter revenue beat consensus and the company raised its 2026 INGREZZA sales guidance, even as reported GAAP profit fell on acquisition-related costs.
-
Ibotta's 28.8% jump on Tuesday: what the evidence shows
Ibotta, Inc. shares rose 28.8% on Tuesday, 5.6x a typical day's move. Here is the clearest evidence-backed explanation.
-
Jazz Pharmaceuticals: profit is lagging sales
Jazz Pharmaceuticals plc is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $4.7 billion, up 13.5% on the year before.
-
Shopify: profit is lagging sales
Shopify Inc. is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $14.2 billion, up 32.5% on the year before.
-
Advanced Energy Industries: growth has picked up
Advanced Energy Industries Inc is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $2.3 billion, up 31.7% on the year before.
-
Fabrinet: growth has picked up
Fabrinet is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $5.1 billion, up 43.0% on the year before.
-
Upwork: the decline in sales is deepening
Upwork, Inc is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $771.2 million, down 1.2% on the year before.
-
Why Allison Transmission shares rose 6.5%: guidance raised for a second straight quarter
Allison Transmission shares rose 6.5% on Tuesday to $$120.48, after third-quarter net sales rose 121.0% to $1,534 million and the company raised full-year guidance for a second consecutive quarter, lifting its free cash flow outlook to $850-$900 million.
-
Peoples Financial Services' 6.7% jump on Monday: what the evidence shows
Peoples Financial Services Corp. shares rose 6.7% on Monday, 4.4x a typical day's move. Here is the clearest evidence-backed explanation.
-
Why XMax shares fell 37.6% despite a $100 million AI infrastructure deal
XMax shares fell 37.6% on 2026-11-02 after disclosing a five-year AI computing agreement that a report linked to its financing commitments rather than its advertised revenue; the drop ran at 15.1x the stock's typical daily swing.
-
Nextpower rallies on a record backlog while free cash flow lags
Nextpower shares rose 15.0% on 2026-11-02 with no confirmed company disclosure that session to explain the scale of the move. The gain followed a quarterly earnings beat and raised guidance, even as free cash flow and operating margin both narrowed.
-
Perion Network's 31.3% jump on Monday: what the evidence shows
Perion Network Ltd. shares rose 31.3% on Monday, 13.6x a typical day's move. Here is the clearest evidence-backed explanation.
-
Symbotic’s balance sheet is growing faster than revenue
Symbotic’s assets are expanding faster than sales, while revenue growth has slowed to 20.6%. Strong cash generation offers a more favourable reading, but its durability matters more than the balance sheet’s size.
-
How to read an earnings report: revenue, EPS, guidance and the estimate
An earnings report is read in order: revenue growth, GAAP versus adjusted EPS, the analysts' estimate, guidance, then cash flow. GE Aerospace's filing for the quarter to 30 September 2026 shows what that sequence reveals beyond the headline profit figure.
-
Jaguar Health: growth has slowed
Jaguar Health, Inc. shares closed at $0.82, their lowest level in a year. Here is how the price compares with the company's own figures and our model's value.
-
Tempus AI: growth has slowed
Tempus AI, Inc. is drawing far more news coverage than usual. Its own filings show twelve-month revenue of $1.5 billion, up 36.6% on the year before.
-
Coherent's net income rose 1,530.7% while operating cash flow fell 87.5%
Coherent Corp.'s trailing twelve-month profit has surged on paper even as the cash it actually collects has collapsed, a split the company's filings don't spell out, even as a capital spending programme now consuming 15.5% of revenue has separately drained free cash flow.
-
What to watch when Cenovus Energy Inc. reports on Wednesday 4 November
Cenovus Energy Inc. reports on Wednesday 4 November, before the market opens. Analysts expect full-year EPS of $3.92; these are the numbers and trends the report will test.
-
What to watch when RED Robin Gourmet Burgers Inc reports on Wednesday 4 November
RED Robin Gourmet Burgers Inc reports on Wednesday 4 November, after the market closes. Analysts expect full-year EPS of −$0.18; these are the numbers and trends the report will test.
-
Brookfield shares jump as LXP deal closes, far outpacing the sector
Brookfield Asset Management shares climbed after Brookfield and CPP Investments completed their acquisition of LXP Industrial Trust, a move too large for the day's peer or market moves to explain on their own.
-
Fed holds rates at 3.75%-4.00%: what changed
The Federal Open Market Committee held its target rate at 3.75% to 4.00% on 28 October, with two members voting for a quarter-point rise as inflation stayed above the Fed's 2% goal.
-
IDEXX shares rose 20.3%: Q3 beat and raised guidance lift diagnostics outlook
IDEXX Laboratories shares rose 20.3% on 2026-11-02 after third-quarter results beat estimates and management raised full-year guidance, even as free cash flow outgrew net income and the operating-margin outlook was trimmed.